![John G. Vossen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van John G. Vossen
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
FABPulous BV
![]() FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands.
8
| Holding Company | Medical Specialties | 8 |
Brightlands Venture Partners BV
![]() Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture Partners is an independent regional venture capital firm headquartered in Brightlands, Netherlands. The firm was founded in 2004.
3
| Holding Company | Investment Managers | 3 |
Limburg Ventures (Management)
![]() Limburg Ventures (Management) Investment ManagersFinance Limburg Ventures (Management) (LVM) is an independent Dutch venture capital firm which was established in 2003 by DSM, a leading international life sciences and advanced chemicals firm; LIOF, the development company for economic development in the Dutch province of Limburg; and the Mourmans Groep venture capital firm. Located in Maastricht, LVM invests in promising start-up firms in life sciences and advanced chemicals and materials. They focus on firms that are willing to relocate to the province of Limburg, Netherlands, and preferably to the firm's Research Campus at Chemelot, where DSM and LIOF have established facilities for start-up companies at DSM's original central research site
2
| Extinct | Investment Managers | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met John G. Vossen via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Residex BV
![]() Residex BV Investment ManagersFinance Residex BV is a private equity and venture capital fund manager based in Apeldoorn, Netherlands. Residex traces their history to 1987 when the firm was set up as Participatiemaatschappij BV in The Hague. The current firm was formally established in 1991. Residex is a subsidiary of Achmea Holding NV which provides insurance and financial services. The ultimate parent firm is Eureko BV, which offers insurance services as well as asset management and banking services. Since 1996, Residex focuses on investments in the healthcare sector and specializes in expansion capital, MBOs, MBIs and re-structuring transactions. They manage a number of venture funds with a healthcare/life sciences focus as well as those in biotechnology and the pharmaceutical industries. | Investment Managers | Private Equity Investor | |
University of Tilburg | College/University | Undergraduate Degree | |
Indiana University | College/University | Undergraduate Degree | |
Indian Institute of Technology New Delhi | College/University | Undergraduate Degree | |
University of Utrecht | College/University | Graduate Degree | |
Polpharma Biologics Utrecht BV
![]() Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
International Institute for Management Development | College/University | Masters Business Admin | |
PharmaCell BV
![]() PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | Biotechnology | Chairman | |
DSM Agro BV
![]() DSM Agro BV Chemicals: AgriculturalProcess Industries DSM Agro BV produces and sells nitrogen fertilizers and industrial products. It offers fertilizers like Nutramon 27 N + 4 MgO, Ammonium nitrate 33.5 N, Agnesamon 22 N + 7 MgO and Urean. The company is headquartered in Sittard, the Netherlands. | Chemicals: Agricultural | Chief Tech/Sci/R&D Officer | |
DSM Venturing BV
![]() DSM Venturing BV Investment ManagersFinance DSM Venturing BV (DSM Venturing) is the venture capital arm of Royal DSM NV in the Netherlands founded in 2001. DSM Venturing BV is headquartered in Geleen. | Investment Managers | Private Equity Investor Private Equity Investor | |
Thuja Capital Management BV
![]() Thuja Capital Management BV Investment ManagersFinance Thuja Capital Management BV is a Venture Capital firm, a subsidiary of Thuja Capital Holding BV founded in 2006 by Harrold van Barlingen. Thuja Capital Management BV is headquartered in Utrecht. | Investment Managers | Private Equity Investor | |
Janssen Pharmaceutica NV
![]() Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Triodos Investment Management BV
![]() Triodos Investment Management BV Investment ManagersFinance Triodos Investment Management BV (Triodos Investment Management) is a private equity/venture capital firm subsidiary of Triodos Bank NV founded in 1980. The firm is headquartered is headquartered in Zeist, Netherlands. | Investment Managers | Private Equity Investor | |
BioMedbooster BV
![]() BioMedbooster BV Miscellaneous Commercial ServicesCommercial Services BioMedbooster BV provides valorization services. It supports businesses in translating their inventions or ideas into products ready for marketing. The company builds bridges between scientific research and industry, especially in life sciences and biomedical technologies. The firm offers evaluation of commercial potential of the invention, market analysis, managing the patenting process, business plan development, financial support for patent application in selected cases, business development financing, finding seed capital, monitoring contracts and payments, strong connections in scientific, industrial and financial communities, finding licensees and monitoring patent infringement. BioMedbooster was founded in 2005 and is headquartered in Maastricht, the Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kenda Capital BV
![]() Kenda Capital BV Investment ManagersFinance Kenda Capital BV (Kenda) is an independent Dutch venture capital firm which was established by Erik Vollebregt in 2001 to manage the Shell Technology Ventures Fund 1 BV. Located in Rijswijk with a U.S. office in Houston, Texas, Kenda manages the Shell Technology Ventures Fund, a large scale investment fund focused at reducing the cost of energy by accelerating the development and deployment of new technologies. The firm's energy sector expertise is fostered through a unique technology relationship with the Shell Group. The Fund also has proprietary access to oil and gas field operations and wells in order to test, prove and demonstrate combinations of new technologies. | Investment Managers | Private Equity Investor | |
AWS Ocean Energy Ltd.
![]() AWS Ocean Energy Ltd. Electric UtilitiesUtilities AWS Ocean Energy Ltd. develops marine wave energy systems for offshore aquaculture and utility power generation. It offers aquaculture solutions, utility power, breakwater systems, active moorings, and consultancy services. The company was founded by Simon Grey, Fred Gardner, and Hans van Breugel in 2004 and is headquartered in Inverness, the United Kingdom. | Electric Utilities | Director/Board Member | |
Arecor Ltd.
![]() Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
ACS Biomarker BV
![]() ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Director/Board Member | |
Kriya Materials BV
![]() Kriya Materials BV Industrial SpecialtiesProcess Industries Kriya Materials BV engages in the development and manufacture of anti-static coatings for plasma television. Its products include antistatic coatings, optical hard coat products, solar heat coatings, anti fouling hard coat and nano dispersion, and hard coat products. Its products are used in liquid crystal display plasma display, touch panels, and window film applications. The company was founded by Hugo Delissen, Edwin Currie, and Mark G. Tilley in 2006 and is headquartered in Geleen, the Netherlands. | Industrial Specialties | Director/Board Member | |
United Telecom NV
![]() United Telecom NV Specialty TelecommunicationsCommunications United Telecom NV develops software technologies for mobile operators. It provides fixed and mobile telephony and VDSL products. The company was founded in 1990 and is headquartered in Rotselaar, Belgium. | Specialty Telecommunications | Director/Board Member | |
Astellas Pharma SAS
![]() Astellas Pharma SAS Medical DistributorsDistribution Services Astellas Pharma SAS wholesales pharmaceutical products. The company was founded in 2005 and is headquartered in Levallois-Perret, France. | Medical Distributors | Corporate Officer/Principal | |
Wageningen University | College/University | Doctorate Degree | |
DCPrime BV
![]() DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
NightBalance BV
![]() NightBalance BV Medical DistributorsDistribution Services NightBalance BV develops and markets sensor-devices for the treatment of sleep apnea. It offers sleep position trainer, a small and light aid which can be worn around the chest with an ergonomic band. The firm's a sleep position sensor which gradually and comfortably trains patients using vibrations to not sleep on their back. The company was founded by Eline van Beest and Thijs van Oorschot in 2009 and is headquartered in The Hague, the Netherlands. | Medical Distributors | Director/Board Member | |
SABIC Ventures BV
![]() SABIC Ventures BV Investment ManagersFinance SABIC Ventures BV is a venture capital firm founded in 2011. The firm headquartered in Netherlands. | Investment Managers | Private Equity Investor | |
Cristal Delivery BV
![]() Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Health Innovations BV
![]() Health Innovations BV Investment ManagersFinance Health Innovations BV is an independent private equity firm founded in 2011. The firm is headquartered in Utrecht, the Netherlands. | Investment Managers | Private Equity Investor | |
Mellon Medical BV
![]() Mellon Medical BV Medical SpecialtiesHealth Technology Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
Nutrileads BV
![]() Nutrileads BV Food: Major DiversifiedConsumer Non-Durables Nutrileads BV develops food ingredi?nts with a specific nutritional value. It identifies promising lead ingredients, develops sustainable and commercially viable production processes and initiates scientific and clinical programs to test the health effects. The company was founded in 2012 by Erik Dam and Ruud Albers and is headquartered in Wageningen, the Netherlands. | Food: Major Diversified | Director/Board Member | |
Caloritum NV
![]() Caloritum NV Industrial ConglomeratesProducer Manufacturing Caloritum NV offers innovative technology to industrial customers. The firm provides transform wasted heat into useful process heat and reduces the total energy bill by saving fossil fuels and CO2 emissions. The company was founded by Wouter Ducheyne and Christian Heeren in 2012 and is headquartered in Antwerp, Belgium. | Industrial Conglomerates | Director/Board Member | |
Livassured BV
![]() Livassured BV Electronic Equipment/InstrumentsElectronic Technology Livassured BV develops monitoring devices for epilepsy patients that identifies nocturnal seizures. The company was founded by Mark Bloemendaal and Asmund Tielens and is headquartered in Vught, the Netherlands. | Electronic Equipment/Instruments | Director/Board Member | |
Alveron Pharma BV
![]() Alveron Pharma BV Pharmaceuticals: MajorHealth Technology Alveron Pharma BV is a Dutch company that develops cyclodextrin-based drugs. The company is based in Nijmegen, Netherlands. The company was founded in 2019. Ben Nichols has been the CEO of the company since 2019. | Pharmaceuticals: Major | Director/Board Member | |
Neuroplast BV
![]() Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016. | Biotechnology | Director/Board Member | |
Pan Cancer T
![]() Pan Cancer T BiotechnologyHealth Technology Pan Cancer T is a company based in Rotterdam, Netherlands that was founded in 2020 by Reno Debets, Dora Hammerl. The Dutch company focuses on advancing next generation TCR T cell therapies for hard-to-treat solid tumors. The company's approach includes exploiting unique targets for T cells that are exclusively and robustly expressed by multiple solid cancers and developing technologies that enhance the durability of the T cells. The company has ongoing R & D programs to develop safe and effective adoptive T cell therapies for patients with triple negative breast cancer as well as cancers of the bladder, ovarium, colorectum, prostate, skin, esophagus, lung, or brain. Rachel Abbott has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
EsoBiotec SA
![]() EsoBiotec SA Miscellaneous Commercial ServicesCommercial Services EsoBiotec SA is a Belgian company that provides research and development on natural sciences and engineering. The company is based in Charleroi, Belgium. The company was founded in 2020 by Jean-Pierre Latere. Jean-Pierre Latere has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
CimCure BV
![]() CimCure BV Miscellaneous Commercial ServicesCommercial Services CimCure BV is a Dutch new generation company founded in 2015 as a spin-off of the VU University Medical Center. CimCure is based in Amsterdam, Netherlands. The company focuses on the design and development of a novel class of active cancer vaccines that target the tumor blood vessels common to most solid tumors. CimCure has discovered and patented multiple highly specific targets and a novel conjugate vaccine technology that can induce polyclonal antibody responses to targets specific to the tumor vasculature. The company aims to combine the proven efficacy of tumor angiogenesis inhibition with the advantages that a vaccine may provide. The company was founded in 2015 by Arjan W. Griffioen, and Diederik Engbersen has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chief Executive Officer | |
FundaMental Pharma GmbH
![]() FundaMental Pharma GmbH Pharmaceuticals: MajorHealth Technology FundaMental Pharma GmbH is a neuroscience company based in Heidelberg, Germany. The German company develops first-in-class small inhibitors for the treatment of a range of neurodegenerative diseases. The company's scientists have discovered an entirely new class of drugs that safely counteract glutamate excitotoxicity, a common cause of neurodegeneration. The company's current focus is on amyotrophic lateral sclerosis (ALS) and Huntington's disease, but the applicability of these molecules extends to a range of neurodegenerative disorders such as dementia and aging-related memory loss. FundaMental Pharma was founded in 2016 by Thomas Schulze, Hilmar Bading, and Daniela Mauceri, and Thomas Schulze has been the CEO since 2016. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Nederland | 30 |
België | 5 |
Verenigd Koninkrijk | 3 |
Verenigde Staten | 2 |
India | 2 |
Sectoraal
Health Technology | 13 |
Finance | 8 |
Consumer Services | 7 |
Commercial Services | 7 |
Process Industries | 3 |
Operationeel
Director/Board Member | 27 |
Private Equity Investor | 14 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 4 |
Undergraduate Degree | 3 |
Sterkste connecties
Insiders | |
---|---|
Michel Briejer | 17 |
Marcel Kloosterman | 10 |
Casper F. Bruens | 7 |
Aruna Subramanian | 7 |
Dick Sietses | 4 |
Erik Wolters | 3 |
Ger Biesbrouck | 2 |
Diederik Engbersen | 2 |
Kim de Boer | 2 |
Jan Glatz | 1 |
Pierre Daemen | 1 |
Conor O’Brien | 1 |
- Beurs
- Insiders
- John G. Vossen
- Bedrijfsconnecties